A Picture of Clinical Trial Supply Asia
In a recent survey published by Pharma IQ, we learnt that 62% of repsondents think China and India hold the most potential for clinical trials in the next 5 years. This along with the result, that over 70% believe they will be outsourcing some element of clinical trials to the BRIC region in the next year, demonsatrate that we can expect much growth in Clinical Trials in Asia in the coming future
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.